MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617086268 A) filed by Pfizer Inc. on July 14, 2026, for Benzodiazepine Pyrazolo Carboxamides As N-Protein Inhibitors.
Inventors include Barrett, Matthew Jeremy; Bedernjak, Alexandre Francois; Bhattacharya, Samit Kumar; Cockerill, George Stuart; Adams, Jan Antoinette Cusi Romero; Good, James Arthur Dudley; Kalgutkar, Amit; Sharma, Raman; and Tillotson, Iii, Joseph.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: The invention relates to benzodiazepine pyrazolo carboxamidesand pharmaceutically acceptable salts thereof as defined in the description; to their use in medicine; to compositions containing them; to processes for their preparation; and to intermediates used in such processes. The compounds of invention inhibit the activity RSV N- proteins and may be useful in the treatment, prevention, suppression, and amelioration of viral infections such as RSV.
Disclaimer: Curated by HT Syndication.
